178 related articles for article (PubMed ID: 8625177)
1. The role of squamous cell carcinoma antigen in the management of laryngeal and hypopharyngeal cancer.
Lara PC; Cuyás JM
Cancer; 1995 Sep; 76(5):758-64. PubMed ID: 8625177
[TBL] [Abstract][Full Text] [Related]
2. Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.
Akbaba S; Held T; Lang K; Hoerner-Rieber J; Zaoui K; Forster T; Rieken S; Plinkert P; Debus J; Adeberg S
Radiat Oncol; 2019 Feb; 14(1):34. PubMed ID: 30782197
[TBL] [Abstract][Full Text] [Related]
3. [Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].
Xu W; Lyu ZH; Sa N; Ma JK; Tian JJ; Feng SH; Cui P; Cao HY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):346-351. PubMed ID: 29764015
[No Abstract] [Full Text] [Related]
4. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma antigen in patients with cancer of the larynx.
Lachowicz MA; Hassmann-Poznańska E; Kozłowski MD; Rzewnicki I
Clin Otolaryngol Allied Sci; 1999 Aug; 24(4):270-3. PubMed ID: 10472458
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer.
Body JJ; Sculier JP; Raymakers N; Paesmans M; Ravez P; Libert P; Richez M; Dabouis G; Lacroix H; Bureau G
Cancer; 1990 Apr; 65(7):1552-6. PubMed ID: 2311066
[TBL] [Abstract][Full Text] [Related]
8. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
[TBL] [Abstract][Full Text] [Related]
9. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
Andrews G; Lango M; Cohen R; Feigenberg S; Burtness B; Mehra R; Ahmed S; Nicolaou N; Gaughan J; Ridge JA
Head Neck; 2011 Oct; 33(10):1433-40. PubMed ID: 21928415
[TBL] [Abstract][Full Text] [Related]
10. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
Kanda M; Koike M; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Omae K; Yamada S; Nakayama G; Kodera Y
Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
[TBL] [Abstract][Full Text] [Related]
11. The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection.
Ogino I; Nakayama H; Kitamura T; Okamoto N; Inoue T
Int J Gynecol Cancer; 2005; 15(4):630-8. PubMed ID: 16014117
[TBL] [Abstract][Full Text] [Related]
12. Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment.
Pras E; Willemse PH; Canrinus AA; de Bruijn HW; Sluiter WJ; ten Hoor KA; Aalders JG; Szabo BG; de Vries EG
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):23-32. PubMed ID: 11777619
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
Esajas MD; Duk JM; de Bruijn HW; Aalders JG; Willemse PH; Sluiter W; Pras B; ten Hoor K; Hollema H; van der Zee AG
J Clin Oncol; 2001 Oct; 19(19):3960-6. PubMed ID: 11579117
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence.
Salvatici M; Achilarre MT; Sandri MT; Boveri S; Vanna Z; Landoni F
Gynecol Oncol; 2016 Jul; 142(1):115-119. PubMed ID: 27117922
[TBL] [Abstract][Full Text] [Related]
16. Posttreatment squamous cell carcinoma antigen predicts treatment failure in patients with cervical squamous cell carcinoma treated with concurrent chemoradiotherapy.
Wang W; Liu X; Hou X; Lian X; Liu Z; Shen J; Sun S; Yan J; Miao Z; Wang D; Meng Q; Fu J; Zhang F; Qiu J; Hu K
Gynecol Oncol; 2019 Nov; 155(2):224-228. PubMed ID: 31500891
[TBL] [Abstract][Full Text] [Related]
17. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
Ogino I; Nakayama H; Okamoto N; Kitamura T; Inoue T
Int J Gynecol Cancer; 2006; 16(3):1094-100. PubMed ID: 16803491
[TBL] [Abstract][Full Text] [Related]
18. [The clinical signifinace of CEA, Cyfra21-1 and SCC in laryngeal carcinoma's clinicopathological parameters].
Rao LH; Zhang L; Tian L; Yan JR; Xiang XY; Yu FB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(15):1182-1186. PubMed ID: 29798354
[No Abstract] [Full Text] [Related]
19. Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers.
Tshering Vogel DW; Zbaeren P; Geretschlaeger A; Vermathen P; De Keyzer F; Thoeny HC
Eur Radiol; 2013 Feb; 23(2):562-9. PubMed ID: 22865270
[TBL] [Abstract][Full Text] [Related]
20. Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
Guo HT; Bi XH; Lei T; Lv X; Yao G; Chen Y; Liu C
BMC Cancer; 2020 May; 20(1):441. PubMed ID: 32429859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
